Presence of Epstein-Barr virus-infected B lymphocytes with thyrotropin receptor antibodies on their surface in Graves' disease patients and in healthy individuals

Autoimmunity

Volumn 47, Issue 3, 2014, Pages 193-200

  Nagata, Keiko ^a   Higaki, Katsumi ^a   Nakayama, Yuji ^a   Miyauchi, Hiromi ^a   Kiritani, Yui ^a   Kanai, Kyosuke ^b   Matsushita, Michiko ^a   Iwasaki, Takeshi ^a   Sugihara, Hirotsugu ^a   Kuwamoto, Satoshi ^a   Kato, Masako ^a   Murakami, Ichiro ^a   Nanba, Eiji ^a   Kimura, Hiroshi ^c   Hayashi, Kazuhiko ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

B lymphocyte; Environmental factors; Latent infection; Pathogenesis; Plasma cell differentiation; Reactivation

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; FLUORESCENT DYE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LEVOTHYROXINE; PROPYLTHIOURACIL; THIAMAZOLE; THYROTROPIN RECEPTOR ANTIBODY; AUTOANTIBODY; THYROTROPIN RECEPTOR;

ADULT; ARTICLE; B LYMPHOCYTE; CELL SELECTION; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; EPSTEIN BARR VIRUS INFECTION; FLOW CYTOMETRY; GRAVES DISEASE; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; THYROIDECTOMY; WESTERN BLOTTING; BLOOD; CASE CONTROL STUDY; CELL MEMBRANE; EPSTEIN BARR VIRUS; FEMALE; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; VIROLOGY;

ADULT; AUTOANTIBODIES; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CELL MEMBRANE; FEMALE; GRAVES DISEASE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RECEPTORS, THYROTROPIN;

EID: 84940285116     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2013.879863     Document Type: Article

References (32)

1. Davies, P., and T. Larsen. 2007. Thyrotoxicosis. In Williams Textbook of Endocrinology, 11th ed. H. M. Kronenberg, S. Melmed, K. S. Polonsky, and P. R. Larsen, eds. Saunders, Philadelphia, PA. p. 333-376.
2. Weetman, A. P., and A. M. McGregor. 1994. Autoimmune thyroid disease: further developments in our understanding. Endocr. Rev. 15: 788-830.
3. Tomer, Y., and A. Huber. 2009. The etiology of autoimmune thyroid disease: a story of genes and environment. J. Autoimmun. 32: 231-239.
4. Tomer, Y., A. Greenberg, G. Barbesino, et al. 2001. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. JCEM. 86: 1687-1693.
5. Ueda, H., J. M. M. Howson, L. Esposito, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 423: 506-511.
6. Kieff, E. D., and A. B. Rickinson. 2006. Epstein-Barr virus and its replication. In Fields Virology, 5th ed. D. M. Knipe and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, PA. p. 2603-2654.
7. Rickinson, A. B., and E. Kieff. 2006. Epstein-Barr virus. In Fields Virology, 5th ed. D. M. Knipe and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, PA. p. 2655-2700.
8. Sutton, R. N. P., R. T. D. Emond, D. B. Thomas, and D. Doniach. 1974. The occurrence of autoantibodies in infectious mononucle-osis. Clin. Exp. Immunol. 17: 427-436.
9. Whittingham, S., J. McNeilage, and I. R. Mackay. 1985. Primary Sjögren's syndrome after infectious mononucleosis. Ann. Intern. Med. 102: 490-493.
10. James, J. A., K. M. Kaufman, A. D. Farris, et al. 1997. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J. Clin. Invest. 100: 3019-3026.
11. Nagata, K., S. Fukata, K. Kanai, et al. 2011. The influence of Epstein-Barr virus reactivation in patients with Graves' disease. Viral Immunol. 24: 143-149.
12. Crawford, D. H., and I. Ando. 1986. EB virus induction is associated with B-cell maturation. Immunology. 59: 405-409.
13. Laichalk, L. L., and D. A. Thorley-Lawson. 2005. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 79: 1296-1307.
14. Kimura, H., K. Miyake, Y. Yamauchi, et al. 2009. Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-Associated lymphoproli-ferative disease. J. Infect. Dis. 200: 1073-1087.
15. Rees Smith, B., and R. Hall. 1974. Thyroid-stimulating immuno-globulins in Graves' disease. Lancet. 2: 427-431.
16. Michelangeli, V., C. Poon, J. Taft, et al. 1998. The prognostic value of thyrotropin receptor antibody measurement in early stages of treatment of Graves' disease with antithyroid drugs. Thyroid. 8: 119-124.
17. Costagliola, S., N. G. Morgenthaler, R. Hoermann, et al. 1999. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. JCEM. 84: 90-97.
18. Frisan, T., V. Levitsky, and M. Masucci. 2001. Generation of lymphoblastoid cell lone (LCLs). In Epstein-Barr Virus Protocols (Method in Molecular Biology Vol. 174). J. Wilson and G. H. W. May, eds. Humana Press, Totowa. p. 125-127.
19. Nilsson, K. 1971. High-frequency establishment of human immunoglobulin-producing lymphoblastoid lines from normal and malignant lymphoid tissue and peripheral blood. Int. J. Cancer. 8: 432-442.
20. Tanaka, K., G. D. Chazenbalk, S. M. McLachlan, and B. Rapoport. 1999. Subunit structure of thyrotropin receptors expressed on the cell surface. J. Biol. Chem. 274: 33979-33984.
21. Oda, Y., J. Sauders, S. Roberts, et al. 1999. Analysis of carbohydrate residues on recombinant human thyrotropin receptor. JCEM. 84: 2119-2125.
22. Roederer, M. 2001. Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 45: 194-205.
23. Perfetto, S. P., P. K. Chattopadhyay, and M. Roederer. 2004. Seventeen-color flow cytometry: unraveling the immune system. Nat. Rev. Immunol. 4: 648-655.
24. Fan, J. L., R. K. Desai, J. S. Dallas, et al. 1994. High frequency of B cells capable of producing anti-thyrotropin receptor antibodies in patients with Graves' disease. Clin. Immunol. Immunopathol. 71: 69-74.
25. Henle, W., G. Kohn, H. zur Hauzen, and G. Henle. 1967. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science. 157: 1064-1065.
26. Nilsson, K., G. Klein, W. Henle, and G. Henle. 1971. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int. J. Cancer. 8: 443-450.
27. Fox, R. I., M. Luppi, H. I. Kang, and P. Pisa. 1991. Reactivation of Epstein-Barr virus in Sjögren's syndrome. Springer Semin. Immunopathol. 13: 217-231.
28. Nagata, Y., H. Inoue, K. Yamada, et al. 2004. Activation of Epstein-Barr virus by saliva from Sjögren's syndrome patients. Immunology 111: 223-229.
29. Nagoya, T., and Hinuma, Y. 1972. Production of infective Epstein-Barr virus in a Burkitt lymphoma cell line, P3HR-1. GANN. 63: 87-93.
30. Sairenji, T., G. Bertoni, M. M. Medveczky, et al. 1988. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220. J. Virol. 62: 2614-2621.
31. Casali P., M. Nakamura, F. Ginsberg-Fellner, and A. L. Notkins. 1990. Frequency of B cells committed to the production of antibodies to insulin in newly diagnosed patients with insulin-dependent diabetes mellitus and generation of high affinity human monoclonal IgG to insulin. J. Immunol. 144: 3741-3747.
32. Nakamura M., S. E. Burastero, Y. Ueki, et al. 1988. Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus. J. Immunol. 141: 4165-4172.